The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)

Cirrhosis of the Liver Clinical Trial

Official title:
The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX-Stent Study)

Status Withdrawn

Clinical Trial Summary

The aim of the study is to choose an optimal stent and to get further knowledge about the mechanisms of the engraftment of a stent.

The occurrence of a hyperplasia of neointima can be minimized by application of a coated stent and a concurrent safety four weekly dual thrombocytes therapy

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02809248
Study type	Interventional
Source	RWTH Aachen University
Contact
Status	Withdrawn
Phase	N/A
Start date	July 2016
Completion date	December 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05178303` - Composition for Treating Cirrhosis and Liver Cancer (SB-1121)	N/A
Enrolling by invitation	`NCT06121492` - Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia	Phase 3
Completed	`NCT04243148` - Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention	N/A
Completed	`NCT02862249` - Trial of Faecal Microbiota Transplantation in Cirrhosis	Phase 3
Completed	`NCT02608658` - Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites	N/A
Completed	`NCT01573325` - HRQoL in the Low MELD Pre-tx Population	N/A
Recruiting	`NCT04116242` - MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease